Press Release Sagimet Biosciences Receives FDA “Study May Proceed” Letter and IND Clearance for Phase 3 Trial in Acne in Adolescent and Adult Patients Aug 13
Press Release Sagimet Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates Aug 11
Press Release Sagimet Biosciences to Participate in the Canaccord Genuity 46th Annual Growth Conference Aug 4